Who Gets Treatment and Why? Evidence, Inequity, and Solutions in Addiction Care | S2 E2

Описание: Access Is the Treatment: How Policy Shapes Opioid Use Disorder Care & Buprenorphine

In this Host Rx episode, Dr. O examines a critical reality in addiction medicine: access is not secondary to treatment, access is the treatment.
Medications for Opioid Use Disorder (MOUD), including buprenorphine, reduce all-cause mortality by approximately 50%. The evidence is clear. Yet in the United States, who receives these medications often depends on race, income, insurance status, and geography.

This episode explores:
Racial disparities in buprenorphine prescribing
Geographic inequities and treatment deserts
Medicaid expansion and insurance barriers
Adolescent access gaps
Telehealth reforms and post-COVID regulatory changes
Structural determinants driving opioid mortality

Grounded in peer-reviewed research and national policy analysis, this episode is designed for clinicians, policymakers, advocates, public health professionals, researchers, trainees in psychiatry and addiction medicine and general public.

Because where you live should not determine whether you survive.

FEATURED ARTICLES
Lagisetty et al., 2019. Buprenorphine Treatment Divide. JAMA Psychiatry.
https://doi.org/10.1001/jamapsychiatr...
Krawczyk et al., 2022. Policy Impact on Buprenorphine Access. JAMA Network Open.
Goedel et al., 2021. Structural Determinants of Treatment Access. American Journal of Psychiatry.
Samples et al., 2022. Telehealth and Buprenorphine Access. Health Affairs.
Williams et al., 2023. Treatment Inequities and Policy Reform. Lancet Psychiatry.
Priest et al., 2022. Adolescent Treatment Access. Journal of Adolescent Health.
Clinical guidance: SAMHSA and CDC


00:00 Welcome to Transformed Minds
01:27 Why Access Matters
04:11 Research on Treatment Gaps
07:07 Clinician Pipeline and Policy
11:16 Frameworks and Care Models
12:31 Buprenorphine vs Methadone Systems
16:07 Geography Youth and Trauma
20:04 Case Study Marcus
22:58 How Buprenorphine Works
25:50 Access Is the Treatment
27:35 Screen Structural Barriers
30:55 Final Call to Advocate